Secondary Bile Acids Improve Risk Prediction for Non‐invasive Identification of Mild Liver Fibrosis in Nonalcoholic Fatty Liver Disease

Dysregulated bile acid (BA) metabolism has been linked to steatosis, inflammation, and fibrosis in nonalcoholic fatty liver disease (NAFLD).